E
vTv Therapeutics Inc. VTVT
$15.35 -$0.65-4.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue 243.94% -431.06% 14.16% 106.67% -98.33%
Gross Profit -124.30% 432.65% -14.16% -106.67% 123.69%
SG&A Expenses -7.67% 4.13% 29.01% 12.30% 14.15%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -1.87% 4.29% 21.20% -10.56% -10.77%
Operating Income -15.57% -3.93% -21.20% 10.56% 24.24%
Income Before Tax -5.03% 0.09% 31.62% 11.12% -2.51%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -3.29% 0.09% 31.62% 11.12% -4.24%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -2.51% -16.61% -43.96% -22.80% -9.49%
Net Income -4.67% -4.49% 28.12% 7.81% -8.14%
EBIT -15.57% -3.93% -21.20% 10.56% 24.24%
EBITDA -15.86% -3.97% -21.29% 10.59% 24.31%
EPS Basic -1.82% 66.91% 72.53% 69.99% 64.79%
Normalized Basic EPS -5.51% 65.77% 71.29% 68.98% 76.00%
EPS Diluted -1.82% 66.91% 72.53% 69.99% 64.79%
Normalized Diluted EPS -5.51% 65.77% 71.29% 68.98% 76.00%
Average Basic Shares Outstanding 2.80% 215.72% 161.69% 207.12% 207.12%
Average Diluted Shares Outstanding 2.80% 215.72% 161.69% 207.12% 207.12%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --